Madrigal Pharmaceuticals

Ultime notizie

Titoli nella lingua originale della fonte.

• Return on invested capital % of Madrigal Pharmaceuticals, Inc. – HAN:YDO1 (si apre in una nuova scheda)

  TradingView · 30 set 2026

• Under an automatic trading plan, director Paul Friedman proposes to sell shares in Madrigal Pharmaceuticals (MDGL). (si apre in una nuova scheda)

  Stock Titan · 28 set 2026

• How New Headquarters Opening At Madrigal Pharmaceuticals (MDGL) Has Changed Its Investment Story (si apre in una nuova scheda)

  Simply Wall Street · 26 set 2026

• MDGL Reinstated by Goldman Sachs -- Price Target Announced at $7 (si apre in una nuova scheda)

  GuruFocus · 24 set 2026

• Goldman Sachs assumes Madrigal Pharmaceuticals stock with buy rating (si apre in una nuova scheda)

  Investing.com India · 24 set 2026

• Goldman Sachs Reinitiates Coverage on Madrigal Pharmaceuticals (MDGL) with Buy Rating and $704 Price Target (si apre in una nuova scheda)

  GuruFocus · 24 set 2026

• People on the Move: Michael Utz Joins Madrigal Pharmaceuticals as Senior Director, Commercial Development - Marketing (si apre in una nuova scheda)

  BioBuzz · 23 set 2026

• Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target (si apre in una nuova scheda)

  Yahoo Finance · 23 set 2026

• Citi Initiates Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Announces Target Price $725 (si apre in una nuova scheda)

  Moomoo · 23 set 2026

• (MDGL) Volatility Zones as Tactical Triggers (si apre in una nuova scheda)

  Stock Traders Daily · 22 set 2026

• Madrigal Pharmaceuticals stock falls 1.80 percent as valuation stays high (si apre in una nuova scheda)

  AD HOC NEWS · 22 set 2026

• Madrigal Grants Equity Awards to 27 New Employees (si apre in una nuova scheda)

  MyChesCo · 21 set 2026

• Madrigal Pharmaceuticals stock trades around 531 dollars as institutional interest stays strong (si apre in una nuova scheda)

  AD HOC NEWS · 21 set 2026

• Madrigal Pharmaceuticals stock holds above 530 dollars after recent ownership change (si apre in una nuova scheda)

  AD HOC NEWS · 20 set 2026

• Can Madrigal Pharmaceuticals (MDGL) Be A Bargain As It Opens Its New Headquarters? (si apre in una nuova scheda)

  Simply Wall Street · 19 set 2026

• How New Headquarters At Madrigal Pharmaceuticals Stock Has Changed Its Investment Story (si apre in una nuova scheda)

  Simply Wall Street · 18 set 2026

• Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) (si apre in una nuova scheda)

  Yahoo Finance · 16 set 2026

• Shapiro Administration Highlights Importance of New Innovate in PA 2.0 Program During Opening of Madrigal Pharmaceuticals’ Headquarters in Montgomery County (si apre in una nuova scheda)

  PA Department of Community & Economic Development (.gov) · 14 set 2026

• Madrigal unveils new HQ with sales of flagship drug on pace to top $1B this year (si apre in una nuova scheda)

  The Business Journals · 14 set 2026

• Madrigal Pharmaceuticals (NASDAQ: MDGL) insider plans another stock sale after recent multimillion-dollar trades (si apre in una nuova scheda)

  Stock Titan · 11 set 2026

• Madrigal at cantor healthcare conference: growth, access and pipeline By Investing.com (si apre in una nuova scheda)

  Investing.com UK · 10 set 2026

• Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You? (si apre in una nuova scheda)

  fool.com · 10 set 2026

• Madrigal Pharmaceuticals (NASDAQ: MDGL) exec plans $3.4M stock sale for tax withholding (si apre in una nuova scheda)

  Stock Titan · 9 set 2026